
|Slideshows|April 18, 2019
What’s New in Schizophrenia and Cardiovascular Disease?
Author(s)Brian Miller, MD, PhD, MPH
5 questions to test your skills, based on recent findings in the literature.
Advertisement
Newsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
New Phase 3 Clinical Vocal Biomarker Data on Brilaroxazine to Treat Negative Symptoms in Schizophrenia
2
The Bind of the Binary: Psychiatry’s Critics and the Law of the Excluded Middle
3
FDA Accepts Investigational New Drug Application for COMP360 for PTSD
4
FDA Grants Breakthrough Therapy Designation to Alixorexton for the Treatment of Narcolepsy Type 1
5

















